153 related articles for article (PubMed ID: 23178380)
1. Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques.
Rosenberg YJ; Laube B; Mao L; Jiang X; Hernandez-Abanto S; Lee KD; Adams R
Chem Biol Interact; 2013 Mar; 203(1):167-71. PubMed ID: 23178380
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized recombinant human butyrylcholinesterase delivered by a nebulizer provides long term protection against inhaled paraoxon in macaques.
Rosenberg Y; Fink J; MacLoughlin R; Ooms-Konecny T; Sullivan D; Gerk W; Mao L; Jiang X; Lees J; Urban L; Rajendran N
Chem Biol Interact; 2019 Aug; 309():108712. PubMed ID: 31201777
[TBL] [Abstract][Full Text] [Related]
3. Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques.
Rosenberg YJ; Gearhart J; Mao L; Jiang X; Hernandez-Abanto S
Chem Biol Interact; 2014 Mar; 210():20-5. PubMed ID: 24384224
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.
Rosenberg Y; Saxena A
Neuropharmacology; 2020 Sep; 174():108150. PubMed ID: 32442543
[TBL] [Abstract][Full Text] [Related]
5. Creation of a protective pulmonary bioshield against inhaled organophosphates using an aerosolized bioscavenger.
Rosenberg YJ; Fink JB
Ann N Y Acad Sci; 2016 Jun; 1374(1):151-8. PubMed ID: 27371808
[TBL] [Abstract][Full Text] [Related]
6. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model.
Rosenberg YJ; Saxena A; Sun W; Jiang X; Chilukuri N; Luo C; Doctor BP; Lee KD
Chem Biol Interact; 2010 Sep; 187(1-3):279-86. PubMed ID: 20211615
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and immunogenicity of a recombinant human butyrylcholinesterase bioscavenger in macaques following intravenous and pulmonary delivery.
Rosenberg YJ; Adams RJ; Hernandez-Abanto S; Jiang X; Sun W; Mao L; Lee KD
Chem Biol Interact; 2015 Dec; 242():219-26. PubMed ID: 26415620
[TBL] [Abstract][Full Text] [Related]
9. Neurotoxicity of acute and repeated treatments of tabun, paraoxon, diisopropyl fluorophosphate and isofenphos to the hen.
Henderson JD; Higgins RJ; Dacre JC; Wilson BW
Toxicology; 1992; 72(2):117-29. PubMed ID: 1566275
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.
Kuca K; Jun D; Junova L; Musilek K; Hrabinova M; da Silva JAV; Ramalho TC; Valko M; Wu Q; Nepovimova E; França TCC
Molecules; 2018 May; 23(5):. PubMed ID: 29735900
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
12. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice.
Sun W; Luo C; Tipparaju P; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):172-6. PubMed ID: 23220586
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
14. Blood and bronchoalveolar lavage fluid acetylcholinesterase levels following microinstillation inhalation exposure to sarin in Guinea pigs.
Che MM; Conti M; Boylan M; Sciuto AM; Gordon RK; Nambiar MP
Inhal Toxicol; 2008 Jul; 20(9):821-8. PubMed ID: 18645722
[TBL] [Abstract][Full Text] [Related]
15. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
16. Proline-Rich Chaperones Are Compared Computationally and Experimentally for Their Abilities to Facilitate Recombinant Butyrylcholinesterase Tetramerization in CHO Cells.
Wang Q; Chen CH; Chung CY; Priola J; Chu JH; Tang J; Ulmschneider MB; Betenbaugh MJ
Biotechnol J; 2018 Mar; 13(3):e1700479. PubMed ID: 29024569
[TBL] [Abstract][Full Text] [Related]
17. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Biochem Pharmacol; 2011 Dec; 82(12):1984-93. PubMed ID: 21968035
[TBL] [Abstract][Full Text] [Related]
19. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
Yang ZP; Dettbarn WD
Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
[TBL] [Abstract][Full Text] [Related]
20. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
